Koya Health Care Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-07-2024
- Paid Up Capital ₹ 0.10 M
as on 12-07-2024
- Company Age 15 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -1.95%
(FY 2020)
- Profit -133.67%
(FY 2020)
- Ebitda -7.88%
(FY 2020)
- Net Worth -23.94%
(FY 2020)
- Total Assets 73.70%
(FY 2020)
About Koya Health Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Purnachandra Koya, Koya Umadevi, and Sudha Dasari serve as directors at the Company.
- CIN/LLPIN
U85120TG2008PTC062364
- Company No.
062364
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Koya Health Care Private Limited offer?
Koya Health Care Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services, Fissures Treatment, Mineral Supplement, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Piles Treatment Services, Anti Inflammatory Drugs, Diclofenac.
Who are the key members and board of directors at Koya Health Care?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Purnachandra Koya  | Director | 20-Feb-2011 | Current |
| Koya Umadevi | Director | 20-Feb-2011 | Current |
| Sudha Dasari | Director | 15-Mar-2019 | Current |
Financial Performance and Corporate Structure Insights of Koya Health Care.
Koya Health Care Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 1.95% decrease. The company also saw a substantial fall in profitability, with a 133.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Koya Health Care?
In 2019, Koya Health Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Koya Health Care?
Unlock and access historical data on people associated with Koya Health Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Koya Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koya Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
